Valuation: Theralase Technologies Inc.

Market Cap 57.44M 40.11M 36.53M 33.66M 30.62M 3.71B 60.37M 410M 163M 2.03B 150M 147M 6.37B P/E 2026 *
-18.5x
P/E 2027 * 9.25x
Enterprise Value 57.44M 40.11M 36.53M 33.66M 30.62M 3.71B 60.37M 410M 163M 2.03B 150M 147M 6.37B EV / Sales 2026 *
73.1x
EV / Sales 2027 * 1.69x
Free-Float
79.6%
Yield 2026 *
-
Yield 2027 * -
1 day-5.41%
1 week-5.41%
Current month-2.78%
1 month-5.41%
3 months-7.89%
6 months-27.08%
Current year+6.06%
1 week 0.17
Extreme 0.17
0.19
1 month 0.17
Extreme 0.17
0.25
Current year 0.16
Extreme 0.16
0.41
1 year 0.14
Extreme 0.145
0.41
3 years 0.14
Extreme 0.14
0.41
5 years 0.14
Extreme 0.14
0.48
10 years 0.12
Extreme 0.12
0.6
Manager TitleAgeSince
Chief Executive Officer - 29/06/2023
Director of Finance/CFO - 27/06/2019
Chief Executive Officer - 15/11/2021
Director TitleAgeSince
Chairman - -
Director/Board Member - 01/01/2008
Director/Board Member - 27/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
8/31/26 A Option

Director

3,360 0.0011%
8/27/26 A Buy

Chief Executive Officer

42,000 0.0142%
8/24/26 A Option

Chief Financial Officer

29,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-5.41%-5.41%-5.41%-5.41% 40.14M
-2.79%-4.38%+16.90%+42.75% 255B
-3.16%-5.43%-0.82%+4.42% 160B
-2.01%-10.04%-27.74%+28.17% 141B
-2.35%-5.32%-56.54%-22.92% 62.31B
-1.95%-4.95%+21.12%+51.59% 59.73B
-1.96%-1.92%+3.84%-14.15% 53.49B
-2.83%-2.06%+17.45%+49.48% 49.43B
-3.51%-4.30%+16.33%+68.80% 44.87B
+1.26%-11.71%-1.58%+48.97% 42.57B
Average -2.52%-2.97%-1.64%+25.17% 87B
Weighted average by Cap. -2.40%-3.60%-0.30%+27.75%

Financials

2026 *2027 *
Net sales 786K 549K 500K 461K 419K 50.82M 826K 5.61M 2.23M 27.76M 2.06M 2.02M 87.11M 33.89M 23.66M 21.55M 19.86M 18.06M 2.19B 35.62M 242M 96.06M 1.2B 88.78M 86.91M 3.76B
Net income -4.12M -2.88M -2.62M -2.42M -2.2M -267M -4.33M -29.41M -11.69M -146M -10.8M -10.58M -457M 6.9M 4.82M 4.39M 4.04M 3.68M 446M 7.25M 49.22M 19.56M 244M 18.08M 17.7M 765M
Net Debt - -
Projected Income Statement - Annual - Theralase Technologies Inc.
Logo Theralase Technologies Inc.
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and drug-activated small molecule compounds and their associated formulations, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses, with minimal impact on surrounding healthy tissue. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which researches, develops, manufactures and distributes cool laser therapy systems to healthcare practitioners, predominantly for the healing of pain.
Employees
20
Date Price Change Volume
20/11/26 CA$0.1750 -5.41% 62,362
19/11/26 CA$0.1850 +2.78% 244,001
18/11/26 CA$0.1800 0.00% 20,570
17/11/26 CA$0.1800 0.00% 61,807
16/11/26 CA$0.1800 -2.70% 70,233
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1850CAD
Average target price
0.7000CAD
Spread / Average Target
+278.38%